# Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

> **NCT00005867** · PHASE3 · COMPLETED · sponsor: **Lymphoma Trials Office** · enrollment: 310 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** bleomycin sulfate
- **DRUG:** CHOP regimen
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** mitoxantrone hydrochloride
- **DRUG:** prednisolone
- **DRUG:** vincristine sulfate

## Key facts

- **NCT ID:** NCT00005867
- **Lead sponsor:** Lymphoma Trials Office
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-01
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 310 (ESTIMATED)
- **Last updated:** 2013-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005867, "Combination Chemotherapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00005867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*